Pharmacokinetics and Safety of Ceftobiprole in Neonates and Infants up to 3 Months Treated With Systemic Antibiotics

NCT02527681 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

15

Enrollment

INDUSTRY

Sponsor class

Stopped on July 07, 2020 due to slow enrollment; there were no safety concerns.

Conditions

Bacterial Infections

Interventions

DRUG: Ceftobiprole medocaril

Sponsor

Basilea Pharmaceutica